HCA Healthcare Names Dr. Michael Cuffe Executive Vice President, Chief Clinical Officer

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced Michael Cuffe, MD, MBA, will become executive vice president and chief clinical officer of HCA Healthcare, effective January 1, 2022.

Dr. Cuffe will be responsible for the company’s clinical agenda. He will lead multiple areas including clinical quality, nursing, care transformation, and clinical informatics. He will also continue his existing responsibilities of leading physician services, which includes urgent care operations, graduate medical education (GME), laboratory services and more than 13,000 employed and managed physicians.

“Dr. Michael Cuffe is a respected clinical and operational leader with a deep understanding of HCA Healthcare’s culture and operations,” said Sam Hazen, chief executive officer of HCA Healthcare. “His clinical background, passion for clinical excellence, and proven leadership at HCA Healthcare make him the right person to support our caregivers, integrate services across the organization, and advance our clinical quality agenda.”

Dr. Cuffe joined HCA Healthcare in 2011 as president and CEO of physician services. Under Dr. Cuffe’s leadership, HCA Healthcare has become the largest sponsor of GME programs in the United States, training more than 5,000 residents and fellows across 61 teaching hospitals. In addition, during his ten years with HCA Healthcare, Dr. Cuffe’s teams have expanded the scope of support they provide to the organization’s physician partners and residents while also broadening the network of care offered to patients through the growth of the company’s urgent care operations.

Prior to HCA Healthcare, Dr. Michael Cuffe served as vice president for Ambulatory Services and chief medical officer for Duke University Health System. He previously served as vice president medical affairs of Duke University Health System and vice dean for the Duke University School of Medicine. Dr. Cuffe is a graduate of MIT, and received his MD and MBA degree from Duke University. He completed his residency in internal medicine and fellowship in cardiology at Duke University.

Previously, the clinical agenda for the organization was led by Jonathan Perlin, MD, Ph.D., who is leaving to become the president of The Joint Commission. Dr. Perlin joined HCA Healthcare in 2006 and established a clinical services organization that uses health information technology and data science to seek to continually improve care and create new clinical protocols. Under Dr. Perlin’s leadership, HCA Healthcare produced the landmark REDUCE MRSA study that demonstrated significant improvements for reducing bloodstream infections, creating a new standard of care.

“I am grateful for Jon’s dedicated service to HCA Healthcare and his continued focus on clinical quality,” said Hazen. “As a leader of our organization for many years, the research and work of his teams have significantly improved care for our patients. We wish him well as he continues to make an impact in healthcare and in the lives of patients.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.